Conavi Medical Corp.
CNVI.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 508.80K | 6.52M | 6.61M | 6.85M | 7.25M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 508.80K | 6.52M | 6.61M | 6.85M | 7.25M |
| Cost of Revenue | -35.90K | 1.07M | 1.37M | 1.71M | 2.22M |
| Gross Profit | 544.70K | 5.45M | 5.23M | 5.15M | 5.03M |
| SG&A Expenses | 4.91M | 4.39M | 4.54M | 5.27M | 5.35M |
| Depreciation & Amortization | 565.40K | 581.30K | 612.10K | 627.60K | 672.90K |
| Other Operating Expenses | 267.00K | 177.30K | 236.10K | 236.10K | 236.10K |
| Total Operating Expenses | 15.00M | 17.13M | 18.09M | 21.49M | 22.58M |
| Operating Income | -14.49M | -10.61M | -11.48M | -14.64M | -15.33M |
| Income Before Tax | -11.63M | -14.71M | -21.57M | -28.52M | -31.61M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.63 | -14.71 | -21.57 | -28.52 | -31.61 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.63M | -14.71M | -21.57M | -28.52M | -31.61M |
| EBIT | -14.49M | -10.61M | -11.48M | -14.64M | -15.33M |
| EBITDA | -14.16M | -10.25M | -11.15M | -14.28M | -14.91M |
| EPS Basic | -0.18 | -0.28 | -2.13 | -3.63 | -4.44 |
| Normalized Basic EPS | -0.11 | -0.12 | -0.78 | -1.52 | -2.05 |
| EPS Diluted | -0.18 | -0.28 | -2.13 | -3.63 | -4.44 |
| Normalized Diluted EPS | -0.11 | -0.12 | -0.78 | -1.52 | -2.05 |
| Average Basic Shares Outstanding | 266.73M | 230.09M | 159.06M | 96.68M | 58.59M |
| Average Diluted Shares Outstanding | 266.73M | 230.09M | 159.06M | 96.68M | 58.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |